Efficacy and Safety of TORS for SCCA
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 5/3/2018 |
| Start Date: | March 2013 |
| Contact: | Bette Ghamandi |
| Email: | bjf8j@hscmail.mcc.virginia.edu |
| Phone: | 434-243-1558 |
A Single Arm Study of Efficacy and Functional Quality of Life in Patients Treated With Transoral Robotic Surgery for Oropharyngeal and Supraglottic Squamous Cell Carcinoma
The purpose of this study is to learn more about the outcomes of treatment of throat and
voice box cancers using transoral robotic surgery (TORS). TORS is a relatively new option
involving the use of the da Vinci surgical robot to remove these cancers through the mouth.
voice box cancers using transoral robotic surgery (TORS). TORS is a relatively new option
involving the use of the da Vinci surgical robot to remove these cancers through the mouth.
Inclusion Criteria:
- Adult male or female
- Diagnosis of either oropharyngeal or supraglottic squamous cell carcinoma
Exclusion Criteria:
- Metastatic disease
We found this trial at
1
site
1215 Lee St
Charlottesville, Virginia 22903
Charlottesville, Virginia 22903
(434) 924-0211
Principal Investigator: Mark J Jameson, MD, PhD
University of Virginia Health System UVA Health System includes a 604-bed hospital, level I trauma...
Click here to add this to my saved trials
